Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer

Significant progress has been made in the understanding of the underlying cancer biology of castration‐resistant prostate cancer (CRPC) with the androgen receptor (AR) signalling pathway remaining implicated throughout the prostate cancer disease continuum. Reactivation of the AR signalling pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Schalken, Jack, Fitzpatrick, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744713/
https://www.ncbi.nlm.nih.gov/pubmed/25818596
http://dx.doi.org/10.1111/bju.13123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744713/
https://www.ncbi.nlm.nih.gov/pubmed/25818596
http://dx.doi.org/10.1111/bju.13123

Ejemplares similares